Skip to main content
Top
Published in:

Open Access 01-12-2017 | Research

Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005–2014

Authors: Dilruba Ahmed, Md Ausrafuggaman Nahid, Abdullah Bashar Sami, Farhana Halim, Nasrin Akter, Tuhin Sadique, Md Sohel Rana, Md Shahriar Bin Elahi, Md Mahbubur Rahman

Published in: Antimicrobial Resistance & Infection Control | Issue 1/2017

Login to get access

Abstract

Background

Bloodstream infections due to bacterial pathogens are a major cause of morbidity and mortality in Bangladesh and other developing countries. In these countries, most patients are treated empirically based on their clinical symptoms. Therefore, up to date etiological data for major pathogens causing bloodstream infections may play a positive role in better healthcare management. The aim of this study was to identify the bacterial pathogens causing major bloodstream infections in Dhaka, Bangladesh and determine their antibiotic susceptibility pattern.

Methods

From January 2005 to December 2014, a total of 103,679 single bottle blood samples were collected from both hospitalized and domiciliary patients attending Dhaka hospital, icddrb, Bangladesh All the blood samples were processed for culture using a BACT/Alert blood culture machine. Further identification of bacterial pathogens and their antimicrobial susceptibility test were performed using standard microbiological procedures.

Results

Overall, 13.6% of the cultured blood samples were positive and Gram-negative (72.1%) bacteria were predominant throughout the study period. Salmonella Typhi was the most frequently isolated organism (36.9% of samples) in this study and a high percentage of those strains were multidrug-resistant (MDR). However, a decreasing trend in the S. Typhi isolation rate was observed and, noticeably, the percentage of MDR S. Typhi isolated declined sharply over the study period. An overall increase in the presence of Gram-positive bacteria was observed, but most significantly we observed the percentage of MDR Gram-positive bacteria to double over the study period. Overall, Gram positive bacteria were more resistant to most of the commonly used antibiotics than Gram-negative bacteria, but the MDR level was high in both groups.

Conclusions

This study identified the major bacterial pathogens involved with BSI in Dhaka, Bangladesh and also revealed their antibiotic susceptibility patterns. We expect our findings to help healthcare professionals to make informed decisions and provide better care for their patients. Also, we hope this study will assist researchers and policy makers to prioritize their research options to face the future challenges of infectious diseases.
Appendix
Available only for authorised users
Literature
1.
go back to reference Tumbarello M, et al. Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy. Antimicrob Agents Chemother. 2010;54(10):4085–91.PubMedPubMedCentralCrossRef Tumbarello M, et al. Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy. Antimicrob Agents Chemother. 2010;54(10):4085–91.PubMedPubMedCentralCrossRef
2.
go back to reference Kanoksil M, et al. Epidemiology, microbiology and mortality associated with community-acquired bacteremia in northeast Thailand: a multicenter surveillance study. PLoS One. 2013;8(1):e54714.PubMedPubMedCentralCrossRef Kanoksil M, et al. Epidemiology, microbiology and mortality associated with community-acquired bacteremia in northeast Thailand: a multicenter surveillance study. PLoS One. 2013;8(1):e54714.PubMedPubMedCentralCrossRef
3.
go back to reference Kollef MH, et al. Epidemiology, microbiology and outcomes of healthcare-associated and community-acquired bacteremia: a multicenter cohort study. J Infect. 2011;62(2):130–5.PubMedCrossRef Kollef MH, et al. Epidemiology, microbiology and outcomes of healthcare-associated and community-acquired bacteremia: a multicenter cohort study. J Infect. 2011;62(2):130–5.PubMedCrossRef
4.
go back to reference Reddy EA, Shaw AV, Crump JA. Community-acquired bloodstream infections in Africa: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10(6):417–32.PubMedPubMedCentralCrossRef Reddy EA, Shaw AV, Crump JA. Community-acquired bloodstream infections in Africa: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10(6):417–32.PubMedPubMedCentralCrossRef
5.
go back to reference Sogaard M, et al. Temporal changes in the incidence and 30-day mortality associated with bacteremia in hospitalized patients from 1992 through 2006: a population-based cohort study. Clin Infect Dis. 2011;52(1):61–9.PubMedCrossRef Sogaard M, et al. Temporal changes in the incidence and 30-day mortality associated with bacteremia in hospitalized patients from 1992 through 2006: a population-based cohort study. Clin Infect Dis. 2011;52(1):61–9.PubMedCrossRef
6.
go back to reference Valles J, et al. Evolution over a 15-year period of clinical characteristics and outcomes of critically ill patients with community-acquired bacteremia. Crit Care Med. 2013;41(1):76–83.PubMedCrossRef Valles J, et al. Evolution over a 15-year period of clinical characteristics and outcomes of critically ill patients with community-acquired bacteremia. Crit Care Med. 2013;41(1):76–83.PubMedCrossRef
7.
go back to reference Valles J, et al. Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival. Chest. 2003;123(5):1615–24.PubMedCrossRef Valles J, et al. Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival. Chest. 2003;123(5):1615–24.PubMedCrossRef
8.
go back to reference Friedman ND, et al. Health care--associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002;137(10):791–7.PubMedCrossRef Friedman ND, et al. Health care--associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002;137(10):791–7.PubMedCrossRef
9.
go back to reference Siegman-Igra Y, et al. Reappraisal of community-acquired bacteremia: a proposal of a new classification for the spectrum of acquisition of bacteremia. Clin Infect Dis. 2002;34(11):1431–9.PubMedCrossRef Siegman-Igra Y, et al. Reappraisal of community-acquired bacteremia: a proposal of a new classification for the spectrum of acquisition of bacteremia. Clin Infect Dis. 2002;34(11):1431–9.PubMedCrossRef
10.
go back to reference Deen J, et al. Community-acquired bacterial bloodstream infections in developing countries in south and southeast Asia: a systematic review. Lancet Infect Dis. 2012;12(6):480–7.PubMedCrossRef Deen J, et al. Community-acquired bacterial bloodstream infections in developing countries in south and southeast Asia: a systematic review. Lancet Infect Dis. 2012;12(6):480–7.PubMedCrossRef
11.
go back to reference (CLSI), C.L.S.I. Performance standards for antimicrobial susceptibility testing: twenty second informational supplement ed, CLSI document M100S-S22. Wayne: CLSI; 2012. (CLSI), C.L.S.I. Performance standards for antimicrobial susceptibility testing: twenty second informational supplement ed, CLSI document M100S-S22. Wayne: CLSI; 2012.
12.
go back to reference (CLSI), C.L.S.I. Performance standards for antimicrobial susceptibility testing: 23rd informational supplement, CLSI document M100S-S22. Wayne: CLSI; 2013. (CLSI), C.L.S.I. Performance standards for antimicrobial susceptibility testing: 23rd informational supplement, CLSI document M100S-S22. Wayne: CLSI; 2013.
13.
go back to reference (CLSI), C.L.S.I. Performance standards for antimicrobial susceptibility testing: 20th informational supplement, CLSI document M100S-S22. Wayne: CLSI; 2010. (CLSI), C.L.S.I. Performance standards for antimicrobial susceptibility testing: 20th informational supplement, CLSI document M100S-S22. Wayne: CLSI; 2010.
14.
go back to reference (CLSI), C.L.S.I. Performance standards for antimicrobial susceptibility testing: fourteenth informational supplement ed, CLSI document M100-S14. Wayne: CLSI; 2004. (CLSI), C.L.S.I. Performance standards for antimicrobial susceptibility testing: fourteenth informational supplement ed, CLSI document M100-S14. Wayne: CLSI; 2004.
15.
go back to reference Pillar CM, et al. Prevalence of multidrug-resistant, methicillin-resistant staphylococcus aureus in the United States: findings of the stratified analysis of the 2004 to 2005 LEADER surveillance programs. Diagn Microbiol Infect Dis. 2008;60(2):221–4.PubMedCrossRef Pillar CM, et al. Prevalence of multidrug-resistant, methicillin-resistant staphylococcus aureus in the United States: findings of the stratified analysis of the 2004 to 2005 LEADER surveillance programs. Diagn Microbiol Infect Dis. 2008;60(2):221–4.PubMedCrossRef
16.
go back to reference Cohen AL, et al. Recommendations for metrics for multidrug-resistant organisms in healthcare settings: SHEA/HICPAC Position paper. Infect Control Hosp Epidemiol. 2008;29(10):901–13.PubMedCrossRef Cohen AL, et al. Recommendations for metrics for multidrug-resistant organisms in healthcare settings: SHEA/HICPAC Position paper. Infect Control Hosp Epidemiol. 2008;29(10):901–13.PubMedCrossRef
17.
go back to reference Critchley IA, et al. Activity of daptomycin against susceptible and multidrug-resistant gram-positive pathogens collected in the SECURE study (Europe) during 2000–2001. J Antimicrob Chemother. 2003;51(3):639–49.PubMedCrossRef Critchley IA, et al. Activity of daptomycin against susceptible and multidrug-resistant gram-positive pathogens collected in the SECURE study (Europe) during 2000–2001. J Antimicrob Chemother. 2003;51(3):639–49.PubMedCrossRef
18.
go back to reference Kallen AJ, et al. Multidrug resistance among gram-negative pathogens that caused healthcare-associated infections reported to the National Healthcare Safety Network, 2006–2008. Infect Control Hosp Epidemiol. 2010;31(5):528–31.PubMedCrossRef Kallen AJ, et al. Multidrug resistance among gram-negative pathogens that caused healthcare-associated infections reported to the National Healthcare Safety Network, 2006–2008. Infect Control Hosp Epidemiol. 2010;31(5):528–31.PubMedCrossRef
19.
go back to reference O’Fallon E, Gautam S, D’Agata EM. Colonization with multidrug-resistant gram-negative bacteria: prolonged duration and frequent cocolonization. Clin Infect Dis. 2009;48(10):1375–81.PubMedCrossRef O’Fallon E, Gautam S, D’Agata EM. Colonization with multidrug-resistant gram-negative bacteria: prolonged duration and frequent cocolonization. Clin Infect Dis. 2009;48(10):1375–81.PubMedCrossRef
20.
go back to reference Paterson DL, Doi Y. A step closer to extreme drug resistance (XDR) in gram-negative bacilli. Clin Infect Dis. 2007;45(9):1179–81.PubMedCrossRef Paterson DL, Doi Y. A step closer to extreme drug resistance (XDR) in gram-negative bacilli. Clin Infect Dis. 2007;45(9):1179–81.PubMedCrossRef
21.
go back to reference Falagas ME, Koletsi PK, Bliziotis IA. The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa. J Med Microbiol. 2006;55(Pt 12):1619–29.PubMedCrossRef Falagas ME, Koletsi PK, Bliziotis IA. The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa. J Med Microbiol. 2006;55(Pt 12):1619–29.PubMedCrossRef
22.
go back to reference Ahmed D, et al. Salmonella enterica serovar typhi strain producing extended-spectrum beta-lactamases in Dhaka, Bangladesh. J Med Microbiol. 2012;61(Pt 7):1032–3.PubMedCrossRef Ahmed D, et al. Salmonella enterica serovar typhi strain producing extended-spectrum beta-lactamases in Dhaka, Bangladesh. J Med Microbiol. 2012;61(Pt 7):1032–3.PubMedCrossRef
24.
go back to reference Naheed A, et al. Burden of typhoid and paratyphoid fever in a densely populated urban community, Dhaka, Bangladesh. Int J Infect Dis. 2010;14 Suppl 3:e93–9.PubMedCrossRef Naheed A, et al. Burden of typhoid and paratyphoid fever in a densely populated urban community, Dhaka, Bangladesh. Int J Infect Dis. 2010;14 Suppl 3:e93–9.PubMedCrossRef
25.
go back to reference Saha SK, et al. Typhoid fever in Bangladesh: implications for vaccination policy. Pediatr Infect Dis J. 2001;20(5):521–4.PubMedCrossRef Saha SK, et al. Typhoid fever in Bangladesh: implications for vaccination policy. Pediatr Infect Dis J. 2001;20(5):521–4.PubMedCrossRef
26.
go back to reference Rahman M, Ahmad A, Shoma S. Decline in epidemic of multidrug resistant Salmonella typhi is not associated with increased incidence of antibiotic-susceptible strain in Bangladesh. Epidemiol Infect. 2002;129(1):29–34.PubMedPubMedCentralCrossRef Rahman M, Ahmad A, Shoma S. Decline in epidemic of multidrug resistant Salmonella typhi is not associated with increased incidence of antibiotic-susceptible strain in Bangladesh. Epidemiol Infect. 2002;129(1):29–34.PubMedPubMedCentralCrossRef
27.
go back to reference Threlfall EJ, Ward LR. Decreased susceptibility to ciprofloxacin in Salmonella enterica serotype typhi, United Kingdom. Emerg Infect Dis. 2001;7(3):448–50.PubMedPubMedCentralCrossRef Threlfall EJ, Ward LR. Decreased susceptibility to ciprofloxacin in Salmonella enterica serotype typhi, United Kingdom. Emerg Infect Dis. 2001;7(3):448–50.PubMedPubMedCentralCrossRef
28.
go back to reference Hassing RJ, et al. Analysis of mechanisms involved in reduced susceptibility to ciprofloxacin in Salmonella enterica serotypes typhi and paratyphi a isolates from travellers to southeast Asia. Int J Antimicrob Agents. 2011;37(3):240–3.PubMedCrossRef Hassing RJ, et al. Analysis of mechanisms involved in reduced susceptibility to ciprofloxacin in Salmonella enterica serotypes typhi and paratyphi a isolates from travellers to southeast Asia. Int J Antimicrob Agents. 2011;37(3):240–3.PubMedCrossRef
29.
go back to reference Cisneros JM, Rodriguez-Bano J. Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment. Clin Microbiol Infect. 2002;8(11):687–93.PubMedCrossRef Cisneros JM, Rodriguez-Bano J. Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment. Clin Microbiol Infect. 2002;8(11):687–93.PubMedCrossRef
30.
go back to reference Cross A, et al. Nosocomial infections due to Pseudomonas aeruginosa: review of recent trends. Rev Infect Dis. 1983;5 Suppl 5:S837–45.PubMedCrossRef Cross A, et al. Nosocomial infections due to Pseudomonas aeruginosa: review of recent trends. Rev Infect Dis. 1983;5 Suppl 5:S837–45.PubMedCrossRef
31.
go back to reference Akram F, et al. Prevalence, clinical features, and outcome of pseudomonas bacteremia in under-five diarrheal children in bangladesh. ISRN Microbiol. 2014;2014:469758.PubMedPubMedCentralCrossRef Akram F, et al. Prevalence, clinical features, and outcome of pseudomonas bacteremia in under-five diarrheal children in bangladesh. ISRN Microbiol. 2014;2014:469758.PubMedPubMedCentralCrossRef
32.
go back to reference Brauers J, et al. Activities of various beta-lactams and beta-lactam/beta-lactamase inhibitor combinations against Acinetobacter baumannii and Acinetobacter DNA group 3 strains. Clin Microbiol Infect. 2005;11(1):24–30.PubMedCrossRef Brauers J, et al. Activities of various beta-lactams and beta-lactam/beta-lactamase inhibitor combinations against Acinetobacter baumannii and Acinetobacter DNA group 3 strains. Clin Microbiol Infect. 2005;11(1):24–30.PubMedCrossRef
33.
go back to reference Fournier PE, Richet H. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis. 2006;42(5):692–9.PubMedCrossRef Fournier PE, Richet H. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis. 2006;42(5):692–9.PubMedCrossRef
35.
go back to reference Zavascki AP, et al. Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review. J Antimicrob Chemother. 2007;60(6):1206–15.PubMedCrossRef Zavascki AP, et al. Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review. J Antimicrob Chemother. 2007;60(6):1206–15.PubMedCrossRef
36.
go back to reference Talukdar PK, et al. Antimicrobial resistance, virulence factors and genetic diversity of Escherichia coli isolates from household water supply in Dhaka, Bangladesh. PLoS One. 2013;8(4):e61090.PubMedPubMedCentralCrossRef Talukdar PK, et al. Antimicrobial resistance, virulence factors and genetic diversity of Escherichia coli isolates from household water supply in Dhaka, Bangladesh. PLoS One. 2013;8(4):e61090.PubMedPubMedCentralCrossRef
38.
go back to reference Boucher HW, Corey GR. Epidemiology of methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2008;46 Suppl 5:S344–9.PubMedCrossRef Boucher HW, Corey GR. Epidemiology of methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2008;46 Suppl 5:S344–9.PubMedCrossRef
39.
go back to reference Williams BG, et al. Estimates of world-wide distribution of child deaths from acute respiratory infections. Lancet Infect Dis. 2002;2(1):25–32.PubMedCrossRef Williams BG, et al. Estimates of world-wide distribution of child deaths from acute respiratory infections. Lancet Infect Dis. 2002;2(1):25–32.PubMedCrossRef
40.
go back to reference Baqui AH, et al. Causes of childhood deaths in Bangladesh: an update. Acta Paediatr. 2001;90(6):682–90.PubMedCrossRef Baqui AH, et al. Causes of childhood deaths in Bangladesh: an update. Acta Paediatr. 2001;90(6):682–90.PubMedCrossRef
41.
go back to reference Brooks WA, et al. Effect of weekly zinc supplements on incidence of pneumonia and diarrhoea in children younger than 2 years in an urban, low-income population in Bangladesh: randomised controlled trial. Lancet. 2005;366(9490):999–1004.PubMedCrossRef Brooks WA, et al. Effect of weekly zinc supplements on incidence of pneumonia and diarrhoea in children younger than 2 years in an urban, low-income population in Bangladesh: randomised controlled trial. Lancet. 2005;366(9490):999–1004.PubMedCrossRef
42.
go back to reference Farha T, Thomson AH. The burden of pneumonia in children in the developed world. Paediatr Respir Rev. 2005;6(2):76–82.PubMedCrossRef Farha T, Thomson AH. The burden of pneumonia in children in the developed world. Paediatr Respir Rev. 2005;6(2):76–82.PubMedCrossRef
43.
go back to reference Mamishi S, et al. Penicillin-resistant trend of Streptococcus pneumoniae in Asia: a systematic review. Iran J Microbiol. 2014;6(4):198–210.PubMedPubMedCentral Mamishi S, et al. Penicillin-resistant trend of Streptococcus pneumoniae in Asia: a systematic review. Iran J Microbiol. 2014;6(4):198–210.PubMedPubMedCentral
44.
go back to reference Brooks WA, et al. Invasive pneumococcal disease burden and implications for vaccine policy in urban Bangladesh. Am J Trop Med Hyg. 2007;77(5):795–801.PubMed Brooks WA, et al. Invasive pneumococcal disease burden and implications for vaccine policy in urban Bangladesh. Am J Trop Med Hyg. 2007;77(5):795–801.PubMed
45.
go back to reference Klevens RM, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA. 2007;298(15):1763–71.PubMedCrossRef Klevens RM, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA. 2007;298(15):1763–71.PubMedCrossRef
47.
Metadata
Title
Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005–2014
Authors
Dilruba Ahmed
Md Ausrafuggaman Nahid
Abdullah Bashar Sami
Farhana Halim
Nasrin Akter
Tuhin Sadique
Md Sohel Rana
Md Shahriar Bin Elahi
Md Mahbubur Rahman
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Antimicrobial Resistance & Infection Control / Issue 1/2017
Electronic ISSN: 2047-2994
DOI
https://doi.org/10.1186/s13756-016-0162-z

Keynote webinar | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the broader systemic effects of menopause, so you can help patients in your clinics through the transition.   

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Watch now

Keynote webinar | Spotlight on adolescent vaping

  • Live
  • Webinar | 29-01-2025 | 18:00 (CET)

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Watch it live: Wednesday 29th January, 18:00-19:30 CET
 

Prof. Ann McNeill
Dr. Debbie Robson
Benji Horwell
Developed by: Springer Medicine
Join the webinar

Keynote webinar | Spotlight on modern management of frailty

Frailty has a significant impact on health and wellbeing, especially in older adults. Our experts explain the factors that contribute to the development of frailty and how you can manage the condition and reduce the risk of disability, dependency, and mortality in your patients.

Prof. Alfonso Cruz-Jentoft
Prof. Barbara C. van Munster
Prof. Mirko Petrovic
Developed by: Springer Medicine
Watch now

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more